Literature DB >> 8983039

Cholinergic activation of phosphoinositide signaling is impaired in Alzheimer's disease brain.

R S Jope1, L Song, R E Powers.   

Abstract

The function of the phosphoinositide signal transduction system was compared in membranes from Alzheimer's disease (AD) and control postmortem brain. [3H]Phosphatidylinositol hydrolysis was concentration-dependently stimulated by GTP[S] and this was 40% lower than controls in AD prefrontal cortical membranes. Carbachol induced a response greater than that of GTP[S] alone, and this response was impaired in AD by 45%. Differential analysis of the receptor-coupled and G-protein contributions to the responses indicated that the G-protein deficit in AD had a predominant influence on the lowered responses to cholinergic agonists. Similar deficits were observed in AD in the responses to five additional cholinergic agonists, including acetylcholine with three different acetylcholinesterase inhibitors. Deficits in stimulated phosphoinositide hydrolysis were regionally selective and these deficits did not correlate directly with reductions in choline acetyltransferase activity in AD tissues. These data demonstrate that in AD there is a brain region-selective, large impairment of cholinergic agonist-induced signal transduction mediated by the phosphoinositide system, which we speculate may impact on amyloid precursor protein processing.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 8983039     DOI: 10.1016/s0197-4580(96)00205-9

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  15 in total

Review 1.  Vaccines for Alzheimer's disease: how close are we?

Authors:  Christopher Janus
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749

2.  Individual differences in neurocognitive aging of the medial temporal lobe.

Authors:  Michela Gallagher; Carlo Colantuoni; Howard Eichenbaum; Rebecca P Haberman; Peter R Rapp; Heikki Tanila; Iain A Wilson
Journal:  Age (Dordr)       Date:  2006-11-25

3.  Brain membrane phospholipid alterations in Alzheimer's disease.

Authors:  J W Pettegrew; K Panchalingam; R L Hamilton; R J McClure
Journal:  Neurochem Res       Date:  2001-07       Impact factor: 3.996

4.  Aggregated beta amyloid peptide 1-40 decreases Ca2+- and cholinergic receptor-mediated phosphoinositide degradation by alteration of membrane and cytosolic phospholipase C in brain cortex.

Authors:  A Zambrzycka; R P Strosznajder; J B Strosznajder
Journal:  Neurochem Res       Date:  2000-02       Impact factor: 3.996

5.  Amyloid beta peptide 25-35 modulates hydrolysis of phosphoinositides by membrane phospholipase(s) C of adult brain cortex.

Authors:  J B Strosznajder; A Zambrzycka; M D Kacprzak; R P Strosznajder
Journal:  J Mol Neurosci       Date:  1999-04       Impact factor: 3.444

6.  Cholinergic changes in the APP23 transgenic mouse model of cerebral amyloidosis.

Authors:  Sonia Boncristiano; Michael E Calhoun; Peter H Kelly; Michelle Pfeifer; Luca Bondolfi; Martina Stalder; Amie L Phinney; Dorothee Abramowski; Christine Sturchler-Pierrat; Albert Enz; Bernd Sommer; Matthias Staufenbiel; Mathias Jucker
Journal:  J Neurosci       Date:  2002-04-15       Impact factor: 6.167

7.  Peroxynitrite modulates tyrosine phosphorylation and phosphoinositide signalling in human neuroblastoma SH-SY5Y cells: attenuated effects in human 1321N1 astrocytoma cells.

Authors:  X Li; P De Sarno; L Song; J S Beckman; R S Jope
Journal:  Biochem J       Date:  1998-04-15       Impact factor: 3.857

8.  Hippocampal Gαq/₁₁ but not Gαo-coupled receptors are altered in aging.

Authors:  Joseph A McQuail; Kathleen N Davis; Frances Miller; Robert E Hampson; Samuel A Deadwyler; Allyn C Howlett; Michelle M Nicolle
Journal:  Neuropharmacology       Date:  2013-01-21       Impact factor: 5.250

9.  Impaired Cholinergic Excitation of Prefrontal Attention Circuitry in the TgCRND8 Model of Alzheimer's Disease.

Authors:  Éliane Proulx; Paul Fraser; JoAnne McLaurin; Evelyn K Lambe
Journal:  J Neurosci       Date:  2015-09-16       Impact factor: 6.167

10.  Alzheimer's disease and metals: a review of the involvement of cellular membrane receptors in metallosignalling.

Authors:  Pavithra C Amadoruge; Kevin J Barnham
Journal:  Int J Alzheimers Dis       Date:  2011-03-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.